Country Risk, Foreign-Exchange Fluctuations, and Investment Recovery in Overseas Businesses
First written in FY2016. 4 of 12 entries say "Restated". Latest entry: FY2026.
Ivy Cosmetics moved to the "Worse" side of this theme in 2023, the same year as the typical company in this theme.
The whole theme swung hardest in 2023: 5 of 12 companies on the "Worse" side.
5 other companies' latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「We currently export the hair-growth product Stem Signal to Taiwan as part of our overseas operations, but have made no exports since August 2023. We plan to increase the number of destination countries in the future.」
The disclosure states that no exports to Taiwan have been made since August 2023, reducing current exposure to overseas operations while maintaining the policy of expanding exports in the future. - FY2025RestatedAnnual report
「We currently export the hair-growth product Stem Signal to Taiwan as part of our overseas operations, with exports having begun in August 2023. We plan to gradually increase the number of destination countries. Country risk and foreign exchange risk exist in each country in which we operate overseas,」
The company reaffirms its policy of continuing exports to Taiwan and adding destination countries, together with the associated country risk and foreign exchange risk. - FY2024RestatedAnnual report
「We currently export the hair-growth product Stem Signal to Taiwan as part of our overseas operations, with exports having begun in August 2023. We plan to gradually increase the number of destination countries.」
Exports to Taiwan are continuing and the company plans to add destination countries, so exposure to country risk and foreign exchange risk associated with overseas operations continues. - FY2024-Q3MaterialisedAnnual report
「Regarding overseas operations, exports to Taiwan of the quasi-drug hair-growth product Medicinal Scalp Care Stem Signal began in August. Revenue for the first nine months was ¥144 thousand, and we expect revenue to grow going forward. Meanwhile, exports to Hong Kong have not progressed, partly due to the impact of the treated water issue at Fukushima Daiichi Nuclear Power Station.」
While exports to Taiwan have begun and renewed exposure to overseas business continues, exports to Hong Kong have not progressed due to external conditions. - FY2024-Q2WorsenedAnnual report
「Regarding overseas operations, exports to Taiwan of the quasi-drug hair-growth product Medicinal Scalp Care Stem Signal began in August. Revenue for the first six months was ¥144 thousand, and we expect revenue to grow going forward. We are also preparing to begin exports to Hong Kong shortly.」
The business progressed from preparing to resume overseas operations to beginning exports to Taiwan and preparing exports to Hong Kong, making renewed exposure to country risk and foreign exchange risk more concrete. - FY2024-Q1WorsenedAnnual report
「Regarding overseas operations, preparations have been completed, and shipments are scheduled to begin from the second quarter onward,」
Preparations to resume overseas operations have been completed, with shipments scheduled from the second quarter onward, making renewed exposure to country risk and foreign exchange risk more concrete. - FY2023WorsenedAnnual report
「We are currently preparing to resume overseas operations. If we expand overseas, country risk and foreign exchange risk will exist in each country, and if overseas operations fail to generate returns commensurate with the initial investment, this may affect our financial condition.」
The disclosure states that preparations have begun to resume overseas operations after a period without such operations, exposing the company again to country risk and foreign exchange risk. - FY2022RestatedAnnual report
「We currently have no overseas operations. If we expand overseas in the future, country risk and foreign exchange risk will exist in each country, and if overseas operations fail to generate returns commensurate with the initial investment, this may affect our financial condition.」
The disclosure continues to describe the current absence of overseas operations and country risk and other risks if overseas operations resume in the future. - FY2021RestatedAnnual report
「We currently have no overseas operations. If we expand overseas in the future, country risk and foreign exchange risk will exist in each country, and if overseas operations fail to generate returns commensurate with the initial investment, this may affect our financial condition.」
The disclosure continues to state that there are no overseas operations and identifies country risk and foreign exchange risk if overseas operations resume in the future. - FY2018MitigatedAnnual report
「Our Group currently has no overseas operations. If we expand overseas in the future, country risk and foreign exchange risk will exist in each country, and if overseas operations fail to generate returns commensurate with the initial investment, this may affect the financial condition of our Group.」
The disclosure states that there are currently no overseas operations and describes overseas risks as general risks that would arise if the business were resumed in the future. - FY2017MitigatedAnnual report
「Our Group operated in Taiwan but withdrew during the fiscal year. If we expand overseas in the future, country risk and foreign exchange risk will exist in each country, and if overseas operations fail to generate returns commensurate with the initial investment, this may affect the financial condition of our Group.」
Withdrawal from the Taiwan business reduced our existing exposure to overseas business risks, and the disclosure was revised to describe the general risks that would apply if overseas expansion resumed. - FY2016First statedAnnual report
「In such cases, country risk and foreign exchange risk exist in each country, and if overseas operations fail to generate returns commensurate with the initial investment, this may affect the financial condition of our Group.」
The risks associated with overseas expansion, centered on Taiwan, are identified as country risk, foreign exchange risk and recovery of the investment.